信利仁寿为于中国注册成立的公司，为集团的联营公司，并已于集团的综合财务报表中采用权益法入 账。于本公告日期，信利仁寿由信利光电持有约29.69%权益、由仁寿产投持有约64.29%权益及由仁寿 集安一号有限合伙持有约6.02%权益。仁寿产投及仁寿集安一号有限合伙均为集团的独立第三方。建议 收购事项完成后，假设集团于第一次投标及第二次投标中均成功中标，信利光电将持有信利仁寿约 41.13%的股权。透过信利光电，公司将间接持有信利仁寿约41.13%的股权，而信利仁寿仍将为集团的 联营公司，并采用权益法于集团的综合财务报表入账。 倘若集团仅于第一次投标或仅于第二次投标中成功中标，则信利光电将持有信利仁寿约35.41%的股 权。透过信利光电，建议收购事项完成后，公司将间接持有信利仁寿约35.41%的股权，而信利仁寿仍 将为集团的联营公司，并采用权益法于集团的综合财务报表入账。信利仁寿主要从事制造及销售液晶体 显示器产品业务。 格隆汇10月22日丨信利国际(00732.HK)发布公告，2025年10月22日，董事会议决透过产权交易所以公开 投标方式提交投标收购仁寿产投所持信利仁寿的共计约11.43%股权，总代价不超过人民 ...

Group 1 - Southbound funds reduced their holdings in Xinli International (00732.HK) by 200,000 shares on September 24, 2025, marking a decrease of 0.12% [1][2] - Over the past five trading days, there have been reductions in holdings for five days, with a total net reduction of 856,000 shares [1][2] - In the last twenty trading days, there were reductions in holdings for twenty days, with a cumulative net reduction of 1.62 million shares [1][2] Group 2 - As of now, southbound funds hold 16 million shares of Xinli International, accounting for 5.22% of the company's total issued ordinary shares [1][2] - Xinli International is primarily engaged in the manufacturing and sales of liquid crystal display (LCD) products, operating through two segments: LCD products and electronic consumer products [2] - The company's product offerings include micro camera modules, fingerprint recognition modules, glass cover products, personal healthcare products such as blood glucose meters, blood pressure monitors, electric toothbrushes, calculators, and circuit boards [2]